Multiple sclerosis trials in Russia
3 trials · From ClinicalTrials.gov, checked 11 November 2026. Ask the study team whether a trial fits you.
- Phase 3Taking peopleAn Extension Study to Assess Impact of Multiple Sclerosis (MS) on Physical Function and Provide Continued Ocrelizumab Treatment
- Where
- Kazan', Kirov, Krasnodar, Krasnoyarsk, Moscow, Moskva, Novosibirsk, Perm, Saint Petersburg, Ulyanovsk, Yekaterinburg
- Age
- 18 years and over
- People
- 500 worldwide
- Run by
- Hoffmann-La Roche
See details and how to joinNCT06675955 · EU 2023-507633-21-01 - Phase 3Taking peopleA Study of the Efficacy and Safety of BCD-281 in Patients With Relapsing-Remitting Multiple Sclerosis
- Where
- Nizhny Novgorod
- Age
- 18 years to 55 years
- People
- 292
- Run by
- Biocad
See details and how to joinNCT07321093 - Phase 1Taking peopleAHSCT With Fludarabine and Cyclophosphamide Based Conditioning Regimes in Patients With Multiple Sclerosis
- Where
- Saint Petersburg
- Age
- 18 years to 65 years
- People
- 200
- Run by
- St. Petersburg State Pavlov Medical University
See details and how to joinNCT05832515